Adcentrx Therapeutics
PrivateLast Round
Series A
Extension
Dec 5, 2023
Total Funding Raised
$101M
Company Overview
Adcentrx Therapeutics is a biotechnology company specializing in protein conjugate therapeutics that enhance treatment options for cancer and other life-threatening diseases through targeted therapies that combine biologics and small molecule payloads.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Adcentrx Therapeutics Comps
Public and private peers based on sector, stage, and business model.
Adcentrx Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A Extension | Dec 5, 2023 | ||||
| Series A | Apr 24, 2023 | ||||
| Series A | Apr 28, 2021 |
Key People
Founding team and executive leadership
Adcentrx Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Abio-X | Series A Extension, Series A |
| Boyu Capital | Series A |
| Zoo Capital | Series A |
| F-Prime Capital | Series A Extension, Series A |
| Eight Roads Ventures | Series A Extension, Series A |
| CBC Group | Series A |
| Trinity Innovation Fund | Series A Extension, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 23, 2025
Will present at the 2025 ASCO Annual Meeting in Chicago.
- Apr 23, 2025
First clinical data for ADRX-0706 to be presented at 2025 ASCO Annual Meeting.
Adcentrx Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Adcentrx Therapeutics's valuation, stock price, and market status.
